S. Korea Ships Malaria Vaccines To N. Korea
This article was originally published in PharmAsia News
South Korea's Korea Centers for Disease Control and Prevention says it has sent $1.22 million worth of supplies to North Korea to guard against malaria, which usually spreads during the summer. Among the supplies are enough drugs to treat 50,000 patients, in addition to test kits and mosquito nets to prevent infections. A South Korean health official said that in addition to helping North Korea cope with the disease, the supplies also are expected to help contain the disease and prevent it from spreading to South Korea. (Click here for more
You may also be interested in...
Lawyer asks US FDA to require another trial before licensing Mesoblast’s stem cell therapy for children with SR-aGVHD; Incyte’s Jakafi is only product approved for the indication.
Hanmi licenses out GLP-1/glucagon receptor dual agonist for NASH to Merck, in a deal worth up to $870m, marking a positive turn for the Korean firm's pipeline after Janssen returned rights last year.
Nomolotus discontinued social media claims that its herbal supplement supports users’ immune systems during the COVID-19 pandemic and customers reviews referencing the virus after the National Advertising Division questioned the statements as misleading.